Allied Market Research
Loading...
0

Digital Therapeutics Market Expected to Reach $13.80 Billion by 2027

 

Report Code : A01787

quote The global digital therapeutics market is expected to grow at a faster rate during the forecast period, owing to increase in smartphone penetration globally, especially in developing countries. Moreover, rise in need to curb healthcare costs and increase in prevalence of chronic diseases are anticipated to supplement the market growth. In addition, the introduction of more sophisticated devices, which are compatible with smartphones and associated programs augments the growth of the market. quote

Onkar Sumant
Manager, Healthcare at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, “Digital Therapeutics Market by Application, Product Type, and Sales Channel: Opportunity Analysis and Industry Forecast, 2020–2027," The global digital therapeutics market size was valued at $2.88 billion in 2019, and is expected to reach $13.80 billion by 2027 with a CAGR of 20.5% during the forecast period. Digital therapeutics is a new category of applications that helps treat diseases by changing patient behavior and providing remote monitoring to improve long-term health outcomes. Digital therapeutics includes a wide range of product types such as mobile applications, wearable devices, and sensors. The diabetes segment accounted for one-fourth share of the global digital therapeutics market in 2019. 

The rise in utilization of smart phones and tablets, coupled with the increase in incidences of chronic diseases boost the market growth. However, lack of awareness regarding healthcare associated with smart phone applications and concerns regarding security or privacy of patient data restricts the market growth. On the contrary, emerging markets offer lucrative opportunities for the key market players.

Based on application segment, obesity is expected to grow at a highest CAGR during the forecast period, owing to the increase in obese population worldwide. This increase in obese population leads to various obesity-related conditions such as heart disease, stroke, type 2 diabetes, and certain types of cancers, which are some of the leading causes of preventable, premature death. In addition, presence of large number of key market players offering digital therapeutics solutions for obesity further contributes to growth of the global digital therapeutics market.

By product type, the software segment holds a dominant portion in the market, accounting for about two-third share of the global digital therapeutics market in 2019. This is mainly due to the increased penetration of smart phones and other smart devices mostly in the developing economies. For instance, according to a survey report by Pew Research Center, the U.S. had a smartphone adoption rate of 81% in 2018. This further increase use of this healthcare application.

Asia-Pacific is expected to witness the highest growth rate for the digital therapeutics market throughout the forecast period. Increase in adoption of smartphones, growth in awareness of newer technologies, and rise in consumer preferences toward healthy lifestyles are prime factors that supplement the adoption of digital therapeutics. Moreover, continued growth in coverage of mobile cellular networks and increase in count of lifestyle diseases such as diabetes, obesity, and others further drive the growth of the Asia-Pacific digital therapeutics market. However, lower accuracy, weak reimbursement coverage, and low adoption of devices among aging population are the factors that hinder the digital therapeutics market growth.

The major companies profiled in this report include 2MORROW, Inc., Akili Interactive Labs, Inc., Click Therapeutics, Inc., Fitbit, Inc. (Twine Health, Inc.), Happify, Inc., Kaia Health, Livongo Health, Inc., Medtronic Plc., Omada Health, Inc., Pear Therapeutics, Inc., Proteus Digital Health, Inc., Resmed, Inc. (Propeller Health), Voluntis, Inc., Welldoc, Inc. Other players operating in the digital therapeutics market include GlaxoSmithKline, Mango Health Inc., Veeva Systems, Healthmine Inc., Blue Mesa, Virta Health Corp, Glooko Inc., and among others.

Key Findings Of The Study 

  • Software is expected to be one of the most lucrative segments, registering a CAGR of 21.0% during the forecast period.
  • The business-to-consumers (B2C) segment accounted for maximum share in the global market in 2019, and is expected to grow at a CAGR of 21.3% during the forecast period. 
  • U.S. dominated the global digital therapeutics market, and is projected to retain this trend throughout the forecast period.
  • India is expected to exhibit the highest growth in the Asia-Pacific digital therapeutics market, registering a CAGR of 26.1% during the forecast period.
  • Saudi Arabia is expected to witness the highest growth in the LAMEA market, growing at a CAGR of 23.8% during the forecast period.
  • North America was the highest contributor to the global digital therapeutics market in 2019.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Tushar Nagose
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

 
 

First time buyer?
Check offers and discount on this report
To get this report

 
Click Here
 
 

quote Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), and Others), Product Type (Software and Device), and Sales Channel (Business-to-Business (B2B), Business-to-Consumer (B2C)): Global Opportunity Analysis and Industry Forecast, 2020–2027 quote

View Report
 
 
Avenue Video Loading...

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 3,711 niche industries and company profiles on more than 12,953 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
rep-img

Published Date Jan 2021

Surgical Equipment Market

Download Sample
rep-img

Published Date Nov 2020

Medical Implant Market

Download Sample
 

Get Fresh content delivered

Get insights on topics that matter to your business. Stay updated on the area that interests you.

 
Get Industry Data Alerts
 

Buy Full Version
"Digital Therapeutics Market"
Purchase Enquiry